- Thursday, October 29, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Clinical Trial Supplies Market By Service (Manufacturing, Packaging, Blinding, and labeling Comparator Sourcing, Logistics, Distribution, Storage, and Retention and Solutions), By Phase (Phase I, Phase II, Phase III, Phase IV, and BA/BE Studies), By Therapeutic Area (Oncology, Neurological and Mental Disorders, Infectious and Immune System Diseases, Digestive System Diseases, Blood Disorders, and Other Therapeutic Areas), By Drug Type (Small-molecule Drugs and Biologic Drugs), and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa)-Global Forecast to 2027.
Global Clinical Trial Supplies Market Overview:
The clinical trial is a research investigation that determines whether a medical strategy, treatment, or device is safe, effective, and valuable for humans use. In addition, these studies help in determining which medical approach experiment is the best for particular diseases. Thus, a medical trial provides the best data for health care decision-making purposes. Clinical trial supplies refer to various equipment and tools for conducting scientific experiments, investigations, and clinical research. Syringe needles, nebulizers, and infusion pumps are the generally used clinical trial supplies. They are primarily utilized for conducting medical trials for treating, detecting, and preventing various ailments, analyzing the effectiveness of the treatment method, and diagnosing metabolic disorders and multiple infections. They also find extensive applications during oncological, respiratory, cardiovascular, and neurological procedures.
Global Clinical Trial Supplies Market Insights
The global clinical trial supplies market size was projected to reach USD 4,843.55 million by 2027, growing at a CAGR of 7.8% during the forecast period, 2020-2027. The major factors are the growth in the biologics pipeline and increasing R&D expenditure in pharmaceutical and biopharmaceutical companies. Additionally, the rising population, high prevalence of diseases, and globalization of clinical trials & harmonization of regulations will spur the global clinical trial supplies industry in the future periods. Furthermore, the rising number of biosimilar drugs in trials and the emerging trend of contract research organizations are expected to witness remarkable growth of clinical trial supplies. Furthermore, the increasing usage of clinical trial supplies to treat numerous diseases such as cancer and HIV and the development of innovative drug delivery systems are expected to propel the demand for clinical trial supplies over the coming years.
Moreover, the rising pressure to cut down R&D costs and the rising need to increase operational efficiency positively impact the market for clinical trial supplies. Furthermore, the rapidly expanding customer base, growing public and private research activities for the development of advanced drugs & treatment methods, and advancement in supply chain management technology are fueling the demand for the clinical trial supplies market. Furthermore, the strategic development among the solution providers and an increase in several clinical trials will bolster the growth of the global clinical trial supplies market share. Additionally, the growing geriatric population, increasing healthcare demands, and increasing patent expiration propels the growth of the clinical trial supplies market across the globe.
Growth Driver
The emerging trend of contract research organizations
The emerging trend of contract research organizations is projected to drive the market during the forecasted period of 2020-2027 at a significant rate. The increasing cost and complexity of the clinical trials have impelled the manufacturers and drug developers to outsource their clinical trial supplies and deliver them to the investigator site. These clinical trials are usually performed by outsourcing to clinical research organizations. CROs enable the biotechnological pharmaceutical and medical instrument companies to outsource research activities on a contractual basis, thereby enhancing the utilization of various trial supplies. Clinical research organizations support drug manufacturers on their road to discover and approve future drugs by absorbing some of the clinical stage’s burdens. Clinical trials usually start with Phase I trials on a small group to determine the safety and required dosage. This is usually in-house or tested locally. The small drug manufacturers and CROs are becoming aware of the importance of logistics and material supply with an end-to-end solution in clinical trials. Thus, the increased outsourcing of R&D activities to CROs is driving the industry growth.
Service Segmental Analysis
Based on the service, the global clinical trial supplies market is segregated into manufacturing, packaging, labeling, and blinding, comparator sourcing, logistics, distribution, storage, and retention and solutions. The logistics segment is estimated to witness the highest growth over the analysis timeframe due to the rising number of clinical trials involving temperature-sensitive products and the globalization of clinical trials.
The comparator sourcing will grow significantly due to the growing focus on comparative drug effectiveness and the rising demand for better supply capabilities.
Phase Segmental Analysis
Based on the phase, the global clinical trial supplies market is categorized into Phase I, Phase II, Phase III, Phase IV, and BA/BE studies. The Phase III segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the fact that phase III trials are the time-consuming, most expensive, difficult to design & run, and takes a longer period to study the drug. Besides, it is a large-scale clinical trial involving around 3000 participants and tests the drug on different populations with other drug combinations and safety and efficacy.
The Phase II segment is poised to witness significant growth over the forecast period. It is due to the surge in the number of outsourced Phases I trials, high capital investment, and larger participants sample population (100 to 300).
Therapeutic Area Segmental Analysis
Based on the therapeutic area, the global clinical trial supplies market is classified into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. The oncology segment is to be the highest revenue share for clinical trial supplies during the forecast period. The segment’s growth is attributed to the increasing number of new treatments & therapies, rising incidence of cancer across the globe, and growing demand for drugs that increase the need for clinical trial supplies.
The infectious and immune system diseases will witness a lucrative growth rate in the estimated period due to the growing prevalence of infectious diseases and the increasing investments from the government to conduct clinical trials for infectious and immune system diseases.
Drug Type Segmental Analysis
The global clinical trial supplies market is segmented into small-molecule drugs & biologic drugs based on the drug type. The biologics segment will dominate the global clinical trial supplies market by 2027. Due to the rising number of patent expiry, rise in use of large molecules, increasing focus on drug development for complex diseases. In addition, the rising demand for biosimilar in both emerging and developed countries is also expected to fuel the growth of the industry.
The small-molecule drugs accounted for the largest share of the clinical trial supplies market in 2019. It is due to their cost-effectiveness and easy convertibility to the oral form.
Region Segmental Analysis
The global clinical trial supplies market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is due to well-established CROs, increasing government initiatives to conduct clinical trials, and rising investments in R&D by pharmaceutical and biopharmaceutical companies.
The Asia Pacific will gain a prominent share of the clinical trial supplies market by 2027. Due to the less-stringent patient recruitment regulations, a larger patient population, and stringent regulations for importing clinical supplies.
Competitor Analysis
Companies such as Almac Group Ltd., Catalent Pharma Solutions Inc., DHL, Parexel, Thermo Fisher Scientific Inc., PCI Services, Sharp Clinical, Biocair, O&M Movianto, KLIFO A/S, Capsugel, UDG Healthcare Plc, Bilcare Limited, PRA Health Sciences Inc, Eurofins Scientific, Marken, N-SIDE and Seveillar Clinical Trial Supplies Pvt. Ltd is the key player in the global clinical trial supplies market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global clinical trial supplies manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to clinical trial supplies
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. In addition, product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
By Drug Type
- Small-molecule Drugs
- Biologic Drugs
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Clinical Trial Supplies Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Service
- Market Size & Forecast,2016-2027
- North America Clinical Trial Supplies Market Overview
- North America Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America Clinical Trial Supplies Market Share & Forecast, 2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Clinical Trial Supplies Market
- By Service
- North America Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Europe Clinical Trial Supplies Market Overview
- Europe Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe Clinical Trial Supplies Market Share & Forecast, 2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Clinical Trial Supplies Market
- By Service
- Europe Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Asia Pacific Clinical Trial Supplies Market Overview
- Asia Pacific Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific Clinical Trial Supplies Market Share & Forecast, 2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Clinical Trial Supplies Market
- By Service
- Asia Pacific Clinical Trial Supplies Market Size & Forecast, 2016-2027
- South America Clinical Trial Supplies Market Overview
- South America Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America Clinical Trial Supplies Market Share & Forecast,2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Clinical Trial Supplies Market
- By Service
- South America Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Middle East & Africa Clinical Trial Supplies Market Overview
- Middle East & Africa Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Middle East & Africa Clinical Trial Supplies Market Share & Forecast, 2016-2027
- By Service
- Manufacturing
- Packaging, Labeling, and Blinding
- Comparator Sourcing
- Logistics
- Distribution, Storage, and Retention
- Solutions
- By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- BA/BE Studies
- By Therapeutic Area
- Oncology
- Neurological and Mental Disorders
- Infectious and Immune System Diseases
- Digestive System Diseases
- Blood Disorders
- Other Therapeutic Areas
- By Drug Type
- Small-molecule Drugs
- Biologic Drugs
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Clinical Trial Supplies Market
- By Service
- Middle East & Africa Clinical Trial Supplies Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Almac Group Ltd
- Catalent Pharma Solutions Inc
- DHL
- Parexel
- Thermo Fisher Scientific Inc
- PCI Services
- Sharp Clinical
- Biocair
- O&M Movianto
- KLIFO A/S
- Capsugel
- UDG Healthcare Pl
- Bilcare Limited
- PRA Health Sciences Inc
- Eurofins Scientific
- Marken
- N-SIDE
- Seveillar Clinical Trial Supplies Pvt. Ltd
- Other Prominent Players
